Saltar al contenido
Merck

USP7 and VCPFAF1 define the SUMO/Ubiquitin landscape at the DNA replication fork.

Cell reports (2021-10-14)
André Franz, Pablo Valledor, Patricia Ubieto-Capella, Domenic Pilger, Antonio Galarreta, Vanesa Lafarga, Alejandro Fernández-Llorente, Guillermo de la Vega-Barranco, Fabian den Brave, Thorsten Hoppe, Oscar Fernandez-Capetillo, Emilio Lecona
RESUMEN

The AAA+ ATPase VCP regulates the extraction of SUMO and ubiquitin-modified DNA replication factors from chromatin. We have previously described that active DNA synthesis is associated with a SUMO-high/ubiquitin-low environment governed by the deubiquitylase USP7. Here, we unveil a functional cooperation between USP7 and VCP in DNA replication, which is conserved from Caenorhabditis elegans to mammals. The role of VCP in chromatin is defined by its cofactor FAF1, which facilitates the extraction of SUMOylated and ubiquitylated proteins that accumulate after the block of DNA replication in the absence of USP7. The inactivation of USP7 and FAF1 is synthetically lethal both in C. elegans and mammalian cells. In addition, USP7 and VCP inhibitors display synergistic toxicity supporting a functional link between deubiquitylation and extraction of chromatin-bound proteins. Our results suggest that USP7 and VCPFAF1 facilitate DNA replication by controlling the balance of SUMO/Ubiquitin-modified DNA replication factors on chromatin.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anticuerpo anti-fosfo-histona H3 (Ser10), marcador de mitosis, Upstate®, from rabbit
Sigma-Aldrich
Anticuerpo anti-ubiquitina, clon P4D1-A11, clone P4D1-A11, Upstate®, from mouse
Sigma-Aldrich
DUB Inhibitor VI, P22077, The DUB Inhibitor VI, P22077 controls the biological activity of DUB. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.